Skip to main content

Advertisement

SpringerLink
Log in

Frequency and characteristics of extremely low accumulation of 123I-metaiodobenzylguanidine (MIBG) in patients with and without cardiovascular diseases

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

Very low accumulation of 123I-metaiodobenzylguanidine (LoMIBG) in the human heart has been reported. This study assessed the frequency and characteristics of LoMIBG in the human heart.

Methods

A total of 2212 patients (male/female ratio 1442/770, mean age 64 ± 12 years) who underwent MIBG imaging were included. LoMIBG was defined as an initial heart-to-mediastinum (H/M) ratio of less than 1.4.

Results

Of the 114 patients with LoMIBG, 2 patients were excluded because of taking imipramine. Patients with LoMIBG were older than those without LoMIBG (P < 0.0001). The main diagnosis and the number of patients with each disease were as follows: 28 of 410 coronary artery disease patients, 13 of 371 vasospastic angina patients, 3 of 86 various arrhythmias patients, 4 of 23 valvular heart disease patients, 9 of 101 dilated cardiomyopathy patients, 13 of 512 essential hypertension patients, 2 of 20 hypertrophic cardiomyopathy patients, 24 of 511 subjects without any definite disease (control), and 16 of 176 patients with miscellaneous diseases. When compared with patients without LoMIBG in each cardiovascular disease, LoMIBG patients had left ventricular function and frequency similar to critically ill patients. In the control group, the subjects with LoMIBG were significantly older (P < 0.0001) and had significantly higher HF (P < 0.03) and lower LF/HF (P < 0.001) than those without LoMIBG. In addition, the incidence of LoMIBG was significantly elevated in the elderly (P < 0.002).

Conclusions

LoMIBG occurred in patients both with various diseases and without obvious diseases. Aging may be one of the mechanisms contributing to LoMIBG, especially in patients without obvious diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yamazaki J, Muto H, Kabano T, Yamashina S, Nanjo S, Inoue A. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy: clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J 2001;141:645–652.

    Article  PubMed  CAS  Google Scholar 

  2. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande JL, Duval AM, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999;40:917–923.

    PubMed  CAS  Google Scholar 

  3. Yamada T, Shimonagata T, Fukunami M, Kumagai K, Ogita H, Hirata A, et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study. J Am Coll Cardiol 2003;41:231–238.

    Article  PubMed  Google Scholar 

  4. Agostini D, Belin A, Amar MH, Darlas Y, Hamon M, Grollier G, et al. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study. J Nucl Med 2000;41:845–851.

    PubMed  CAS  Google Scholar 

  5. Marini C, Giorgetti A, Gimelli A, Kusch A, Sereni N, L’abbate A, et al. Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 2005;32:682–688.

    Article  PubMed  Google Scholar 

  6. Simula S, Lakka T, Laitinen T, Remes J, Kettunen R, Kuikka J, et al. Cardiac adrenergic denervation in patients with non-Q-wave versus Q-wave myocardial infarction. Eur J Nucl Med 2000;27:816–821.

    Article  PubMed  CAS  Google Scholar 

  7. Bengel FM, Barthel P, Matsunari I, Schmidt G, Schwaiger M. Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy. J Nucl Med 1999;40:904–910.

    PubMed  CAS  Google Scholar 

  8. Hartikainen J, Mustonen J, Kuikka J, Vanninen E, Kettunen R. Cardiac sympathetic denervation in patients with coronary artery disease without previous myocardial infarction. Am J Cardiol 1997;80:273–277.

    Article  PubMed  CAS  Google Scholar 

  9. Sakata K, Shirotani M, Yoshida H, Kurata C. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension. J Am Coll Cardiol 1998;32:438–443.

    Article  PubMed  CAS  Google Scholar 

  10. Taki J, Yoshita M, Yamada M, Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 2004;18:453–461.

    Article  PubMed  Google Scholar 

  11. Kashihara K, Ohno M, Kawada S, Okumura Y. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson’s disease and dementia with Lewy bodies. J Nucl Med 2006;47:1099–1101.

    PubMed  CAS  Google Scholar 

  12. Estorch M, Camprecios M, Flotats A, Mari C, Berna L, Catafau AM, et al. Sympathetic reinnervation of cardiac allografts evaluated by 123I-MIBG imaging. J Nucl Med 1999;40:911–916.

    PubMed  CAS  Google Scholar 

  13. Delahaye N, Dinanian S, Slama MS, Mzabi H, Samuel D, Adams D, et al. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med 1999;26:416–424.

    Article  PubMed  CAS  Google Scholar 

  14. Wieland DM, Wu J, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131]iodobenzylguanidine. J Nucl Med 1980;21:349–353.

    PubMed  CAS  Google Scholar 

  15. Schofer J, Spielmann R, Schuchert A, Weber K, Schluter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988;12:1252–1258.

    Article  PubMed  CAS  Google Scholar 

  16. Morozumi T, Fukuchi K, Uehara T, Kusuoka H, Hori M, Nishimura T. Abnormal iodine-123-MIBG images in healthy volunteers. J Nucl Med 1996;37:1686–1688.

    PubMed  CAS  Google Scholar 

  17. Mayer S, Karanikas G, Rodrigues M, Sinzinger H. Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium. Eur J Nucl Med 2000;27:340–345.

    Article  PubMed  CAS  Google Scholar 

  18. Nakagawa M, Iwao T, Ishida S, Yonemochi H, Fujino T, Saikawa T, et al. Circadian rhythm of the signal averaged electrocardiogram and its relation to heart rate variability in healthy subjects. Heart 1998;79:493–496.

    PubMed  CAS  Google Scholar 

  19. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072–1083.

    PubMed  CAS  Google Scholar 

  20. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996;93:1667–1676.

    PubMed  CAS  Google Scholar 

  21. Liang CS. Sympatholysis and cardiac sympathetic nerve function in the treatment of congestive heart failure. J Am Coll Cardiol 2003;42:549–551.

    Article  PubMed  CAS  Google Scholar 

  22. Joho S, Asanoi H, Takagawa J, Kameyama T, Hirai T, Nozawa T, et al. Cardiac sympathetic denervation modulates the sympathoexcitatory response to acute myocardial ischemia. J Am Coll Cardiol 2002;39:436–442.

    Article  PubMed  Google Scholar 

  23. Schmidt RE. Neuropathology and pathogenesis of diabetic autonomic neuropathy. Int Rev Neurobiol 2002;50:257–292.

    Article  PubMed  CAS  Google Scholar 

  24. Amino T, Orimo S, Itoh Y, Takahashi A, Uchihara T, Mizusawa H. Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol 2005;15:29–34.

    PubMed  Google Scholar 

  25. Somsen GA, Verberne HJ, Fleury E, Righetti A. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies. J Nucl Cardiol 2004;11:126–133.

    Article  PubMed  Google Scholar 

  26. Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995;36:969–974.

    PubMed  CAS  Google Scholar 

  27. Akamatsu FE, De-Souza RR, Liberti EA. Fall in the number of intracardiac neurons in aging rats. Mech Ageing Dev 1999;109:153–161.

    Article  PubMed  CAS  Google Scholar 

  28. Esler MD, Thompson JM, Kaye DM, Turner AG, Jennings GL, Cox HS, et al. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation 1995;91:351–358.

    PubMed  CAS  Google Scholar 

  29. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled metaiodobenzylguanidine (MIBG). Nucl Med Commun 1992;13:513–521.

    Article  PubMed  CAS  Google Scholar 

  30. Yamakado K, Takeda K, Kitano T, Nakagawa T, Futagami Y, Konishi T, et al. Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy. Eur J Nucl Med 1992;19:265–270.

    Article  PubMed  CAS  Google Scholar 

  31. Arimoto T, Takeishi Y, Fukui A, Tachibana H, Nozaki N, Hirono O, et al. Dynamic 123I-MIBG SPECT reflects sympathetic nervous integrity and predicts clinical outcome in patients with chronic heart failure. Ann Nucl Med 2004;18:145–150.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto, Shizuoka, 411-8777, Japan

    Kazuyuki Sakata, Kei Iida & Nao Motiduki

  2. Division of Diagnostic Radiology, Shizuoka Cancer Center Hospital, Shizuoka, Japan

    Yoshihiro Nakaya

Authors
  1. Kazuyuki Sakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kei Iida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nao Motiduki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshihiro Nakaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuyuki Sakata.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakata, K., Iida, K., Motiduki, N. et al. Frequency and characteristics of extremely low accumulation of 123I-metaiodobenzylguanidine (MIBG) in patients with and without cardiovascular diseases. Ann Nucl Med 22, 743–749 (2008). https://doi.org/10.1007/s12149-008-0169-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-008-0169-5

Keywords

Search

Navigation